Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1979-10-26
pubmed:abstractText
Metaplastic epithelial cells are often observed lining alveoli in bleomycin-induced pulmonary fibrosis. The hypothesis that these cellular changes are induced by the direct action of the drug on differentiating Type 2 cells is now examined in a sequential study to correlate the presence of 3H bleomycin in the lung with the pattern of injury and repair of the alveolar epithelium. A single intravenous dose or multiple small intraperitoneal doses induce focal necrosis of Type 1 epithelial cells followed by Type 2 cell regeneration. At the time of maximal deoxyribonucleic acid (DNA) synthesis in these cells, significant amounts of 3H bleomycin are demonstrable in the lung by scintillation counting; and in autoradiographs, the drug appears to concentrate in epithelial cells. Subsequently many abnormal Type 2 cells are seen. Some are binucleate, and others show nuclear disruption. The usual process of differentiation to Type 1 cells does not occur; instead, a variety of epithelial forms are found, including fetal-like tubular structures and ciliated and squamous metaplastic cells. The correlation of epithelial injury and repair with the direct demonstration of bleomycin in the lung indicates that Type 2 cells are susceptible to injury in the division and differentiation phases of the cell cycle and may then produce a variety of inappropriate alveolar lining cells.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-1036675, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-4123792, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-4139043, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-4141224, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-4566990, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-4812806, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-4975612, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-5021311, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-5337399, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-5476243, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-57003, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-60170, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-60174, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-63965, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-66869, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-66980, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-68683, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-71149, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-830993, http://linkedlifedata.com/resource/pubmed/commentcorrection/89815-923747
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0002-9440
pubmed:author
pubmed:issnType
Print
pubmed:volume
96
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
531-44
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1979
pubmed:articleTitle
Bleomycin-induced injury and metaplasia of alveolar type 2 cells. Relationship of cellular responses to drug presence in the lung.
pubmed:publicationType
Journal Article